We’re patients & families dedicated to improving outcomes for people with oncogene-driven lung cancer through education, support, and powering cutting-edge research.
This #WorldCancerDay @younglungcancer.bsky.social & OCR honour the people who steady the spin: clinicians, researchers, nurses, fellow patients, families.
Who helps you turn your world downside up.
#LCSM
This #WorldCancerDay @younglungcancer.bsky.social & OCR honour the people who steady the spin: clinicians, researchers, nurses, fellow patients, families.
Who helps you turn your world downside up.
#LCSM
@yvonnediaz.bsky.social @oncogenecancer.bsky.social
oncodaily.com/voices/yvonn...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
@yvonnediaz.bsky.social @oncogenecancer.bsky.social
oncodaily.com/voices/yvonn...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Subscribe to receive patient stories, practical support & updates from us, shared occasionally & with care.
Join our community here: 👇
oncogenecancerresearch.eo.page/rymgx
#LCSM
Subscribe to receive patient stories, practical support & updates from us, shared occasionally & with care.
Join our community here: 👇
oncogenecancerresearch.eo.page/rymgx
#LCSM
In our 1st year, we focused on helping our community live longer & better lives, through empowerment, advocacy & research.
Thank you for walking alongside us. This is just the beginning.
👉 oncogeneresearch.org/annual-report
#LCSM
In our 1st year, we focused on helping our community live longer & better lives, through empowerment, advocacy & research.
Thank you for walking alongside us. This is just the beginning.
👉 oncogeneresearch.org/annual-report
#LCSM
5 yr survival rates for some hard to treat cancers have increased.
Liver cancer, with a 7% relative survival rate in the 1990s rose to 22%
Lung cancer- 15% to 28%
Myeloma- 32% to 62%
This is in part due to early detection & better treatment.
🧪 www.cancer.org/research/acs...
5 yr survival rates for some hard to treat cancers have increased.
Liver cancer, with a 7% relative survival rate in the 1990s rose to 22%
Lung cancer- 15% to 28%
Myeloma- 32% to 62%
This is in part due to early detection & better treatment.
🧪 www.cancer.org/research/acs...
Pleasure to have our Chair @yvonnediaz.bsky.social represent the patient voice at @thermofishersci.bsky.social European meeting
Pleasure to have our Chair @yvonnediaz.bsky.social represent the patient voice at @thermofishersci.bsky.social European meeting
We discuss brain mets, brain surgery, and their implications for driving in the UK. We also talked about returning to work and then adjusting my life so I can stop working.
youtu.be/yIWw0U2yg5c?...
We discuss brain mets, brain surgery, and their implications for driving in the UK. We also talked about returning to work and then adjusting my life so I can stop working.
youtu.be/yIWw0U2yg5c?...
Professor Elena Klenova, a scientist w background in cancer research & education & an ALK+ patient, explains ALK #lungcancer in clear, accessible terms - from biology to TKIs.
Written for patients & clinicians alike.
oncogeneresearch.org/patient-publis…
Professor Elena Klenova, a scientist w background in cancer research & education & an ALK+ patient, explains ALK #lungcancer in clear, accessible terms - from biology to TKIs.
Written for patients & clinicians alike.
oncogeneresearch.org/patient-publis…
Years for others.
More than one doctor.
More than one misdiagnosis.
Delayed #lungcancer diagnosis is not rare, especially when you are young & do not fit the “profile”.
Help us change the narrative. Help us create more awareness.
#LCSM
Years for others.
More than one doctor.
More than one misdiagnosis.
Delayed #lungcancer diagnosis is not rare, especially when you are young & do not fit the “profile”.
Help us change the narrative. Help us create more awareness.
#LCSM
Thank you for showing up in big ways and small. Here’s to a better 2026 for all of us.
Happy new year! #HNY2026
Thank you for showing up in big ways and small. Here’s to a better 2026 for all of us.
Happy new year! #HNY2026
This @lungcancerstoday.bsky.social article shares a recap from Dr Mara Antonoff @iaslc.bsky.social @ascocancer.bsky.social #NACLC on surgery in oligometastatic lung cancer.
Have a read 👇
www.lungcancerstoday.com/post/the-ias...
This @lungcancerstoday.bsky.social article shares a recap from Dr Mara Antonoff @iaslc.bsky.social @ascocancer.bsky.social #NACLC on surgery in oligometastatic lung cancer.
Have a read 👇
www.lungcancerstoday.com/post/the-ias...
@oncogenecancer.bsky.social
oncodaily.com/voices/careg...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #OncogeneCancerResearch
@oncogenecancer.bsky.social
oncodaily.com/voices/careg...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #OncogeneCancerResearch
For those living with cancer, scans and worries do not stop.
We are thinking of everyone navigating this season alongside cancer, and thanking those working every day to improve outcomes.
Wishing you rest, love, and peace.
#LCSM
For those living with cancer, scans and worries do not stop.
We are thinking of everyone navigating this season alongside cancer, and thanking those working every day to improve outcomes.
Wishing you rest, love, and peace.
#LCSM
In this part, I discuss my advocacy work, especially my work with Greater Manchester Cancer Alliance.
We also talk about who inspired me to become a patient advocate, Cameron Millar
youtu.be/8wRLznxVN0U
1/2
In this part, I discuss my advocacy work, especially my work with Greater Manchester Cancer Alliance.
We also talk about who inspired me to become a patient advocate, Cameron Millar
youtu.be/8wRLznxVN0U
1/2
Be sure to watch the full interview to learn about how hard it was to get diagnosed and how he’s supporting others.
🎙️youtube.com/playlist?list=…
#LCSM
Be sure to watch the full interview to learn about how hard it was to get diagnosed and how he’s supporting others.
🎙️youtube.com/playlist?list=…
#LCSM
It's why @thermofishersci.bsky.social José Luis Costa believes in continued innovation.
#StoriesOfLungCancer #LCAM25
It's why @thermofishersci.bsky.social José Luis Costa believes in continued innovation.
#StoriesOfLungCancer #LCAM25
@yleyfman.bsky.social
oncodaily.com/voices/yan-l...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
@yleyfman.bsky.social
oncodaily.com/voices/yan-l...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
As Nuvalent’s Dr Henry Pelish reminds us — let’s keep pushing science’s limits.
#StoriesOfLungCancer #LCAM25
As Nuvalent’s Dr Henry Pelish reminds us — let’s keep pushing science’s limits.
#StoriesOfLungCancer #LCAM25
If you're 50–80 with a smoking history, ask your doctor about a low-dose CT lung screening. bit.ly/487gjDn
If you're 50–80 with a smoking history, ask your doctor about a low-dose CT lung screening. bit.ly/487gjDn
This video created w @thermofishersci.bsky.social is a great resource for anyone diagnosed.
Help share to empower & inform more people👇
www.oncogeneresearch.org/biomarker-te...
This video created w @thermofishersci.bsky.social is a great resource for anyone diagnosed.
Help share to empower & inform more people👇
www.oncogeneresearch.org/biomarker-te...
This troubling news came out.
www.nbcnews.com/nightly-news...
This troubling news came out.
www.nbcnews.com/nightly-news...